Zions Bancorporation’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-986
Closed -$98K 1021
2019
Q3
$98K Hold
986
0.01% 334
2019
Q2
$91K Sell
986
-39
-4% -$3.7K 0.01% 313
2019
Q1
$97K Buy
+1,025
New +$89.6K 0.02% 310
2018
Q4
Sell
-964
Closed -$86K 846
2018
Q3
$86K Buy
+964
New +$85.2K 0.02% 256
2018
Q2
Sell
-745
Closed -$66K 760
2018
Q1
$66K Sell
745
-162
-18% -$15.6K 0.01% 243
2017
Q4
$95K Sell
907
-4,823
-84% -$544K 0.02% 240
2017
Q3
$835K Buy
5,730
+5,583
+3,798% +$760K 0.12% 105
2017
Q2
$19K Sell
147
-98
-40% -$12K ﹤0.01% 292
2017
Q1
$30K Sell
245
-325
-57% -$38.9K 0.01% 240
2016
Q4
$66K Buy
570
+41
+8% +$4.57K 0.01% 206
2016
Q3
$54K Buy
529
+48
+10% +$5.2K 0.01% 223
2016
Q2
$50K Sell
481
-48
-9% -$4.96K 0.01% 213
2016
Q1
$57K Sell
529
-8
-1% -$824 0.01% 223
2015
Q4
$53K Buy
537
+66
+14% +$7.64K 0.01% 207
2015
Q3
$55K Buy
+471
New +$58.5K 0.01% 207
2015
Q2
Sell
-532
Closed -$61K 942
2015
Q1
$61K Buy
+532
New +$63.6K 0.01% 203

Other funds holding CELG

Zions Bancorporation's CELG Position: Q4 2019 in Review

Zions Bancorporation sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 986 shares — an estimated $98K sold.

Zions Bancorporation first reported a position in CELG in Q1 2015 and held it in 16 quarters. The position peaked at $835K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Zions Bancorporation reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Zions Bancorporation sold 986 Celgene Corp shares in Q4 2019, an estimated $98K.
  • Zions Bancorporation first reported a position in Celgene Corp in Q1 2015 and held it in 16 quarters.
  • Zions Bancorporation's Celgene Corp position peaked at $835K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Zions Bancorporation's 13F filing for Q4 2019, filed 14 Feb 2020.